Ə0V.Lpehuo: Department of Health & Human Services
Ə0V.Lpehuo: Department of Health & Human Services
Ə0V.Lpehuo: Department of Health & Human Services
Re: K151749
Trade/Device Name: SOMATOM Scope/Scope Power
Regulation Number: 21 CFR 892.1750
Regulation Name: Computed tomography x-ray system
Regulatory Class: II
Product Code: JAK
Dated: March 7, 2016
Received: March 9, 2016
This letter corrects our substantially equivalent letter of March 18, 2016.
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act.
The general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability
warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to additional controls. Existing major regulations affecting your device can be
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
Page 2 – Ms. Kimberly Mangum
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041
or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note
the regulation entitled, sMisbranding by reference to premarket notifications (21CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21
CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH’s Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the
Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301)
796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Enclosure
Special 510(k) Submission: SOMATOM Scope CT systems
K151749
Submitted by:
Siemens Medical Solutions USA, Inc.
51 Valley Stream Parkway
Malvern, PA 19355
Date Prepared: October 30, 2015
1. General Information:
Importer/Distributor Establishment:
Registration Number: 2240869
Siemens Medical Solutions, Inc.
40 Liberty Boulevard
Mail code: 65-1A
Malvern, PA 19355
2. Contact Person:
Kimberly Mangum
Technical Specialist, Regulatory Affairs Submissions
Siemens Medical Solutions, Inc. USA
40 Liberty Boulevard, 65-1A
Malvern, PA 19355-1406
Phone: (610) 448-6477
Fax: (610) 640-4481
Email: kimberly.mangum@siemens.com
3. Device Name and Classification
Product Name: SOMATOM Scope
Propriety Trade Name: SOMATOM Scope (with syngo® CT VC30-
easyIQ version)
Classification Name: Computed Tomography X-ray System
Classification Panel: Radiology
CFR Section: 21 CFR §892.1750
Device Class: Class II
Product Code: JAK
4. Substantial Equivalence:
Siemens SOMATOM Scope/Scope Power with software version
SOMARIS/5 VC30 syngo® CT VC30-easyIQ version is substantially
equivalent to the following medical devices in commercial distribution.
Table 1 Predicate Devices
Predicate Device Name and 510(k)
Clearance Date
Manufacturer number
Primary Predicate Device:
K140912 09/15/2014
Siemens SOMATOM Scope/Scope Power
with SOMARIS/5 VC28
Secondary Predicate Device:
K143401 04/06/2015
Siemens SOMATOM Definition Edge with
SOMARIS/7 VA48
5. Device Description:
The Siemens SOMATOM Scope/Scope Power are Computed Tomography
X- ray Systems which feature a continuously rotating tube-detector system
and function according to the fan beam principle. The system software is a
command-based program used for patient management, data management,
X-ray scan control, image reconstruction, and image archive/evaluation.
(*spiral planes: the axial planes resulted from the continuous rotation of
detectors and xray tube, and the simultaneous translation of the patient.)
8. Nonclinical Testing:
SOMATOM Scope/Scope Power configured with software version syngo®
CT VC30-easyIQ version is designed to fulfill the requirements of the
following standards:
IEC 60601-2-44: Medical electrical equipment – Part 2-44: Particular
requirements for the safety of X-ray equipment for computed
tomography – Ed. 3.1
IEC 61223-3-5: Evaluation and routine testing Evaluation and routine
testing in medical imaging departments - Part 3-5: Acceptance tests –
Imaging performance of computed tomography X-ray equipment
CORRIGENDUM 1
NEMA XR-25: Computed Tomography Dose Check
IEC 61223-2-6: Evaluation and routine testing in medical imaging
departments – Part 2-6: Constancy tests – Imaging performance of
computed tomography X-ray equipment
NEMA PS 3.1 – 3.20 (2011): Digital Imaging and Communications in
Medicine DICOM) Set
IEC 62304 Ed. 1.0: Medical device software – software life cycle
processes
IEC 60601-1: Medical electrical equipment – Part 1: General
requirements for Safety, 2005
IEC 60601-1-6 : 2010; Medical electrical equipment - Part 1-6: General
requirements for basic safety and essential performance -- Collateral
Standard: Usability
ISO 14971: Medical devices – Application of risk management to
medical devices
NEMA XR-29: Standard Attributes on CT Equipment Related to Dose
Optimization and Management
NEMA XR-26: Access Controls for Computed Tomography—
Identification, Interlocks, and Logs
IEC/ISO 10918: Information Technology – Digital Compression and
Coding of Continuous-Tone Still Images: Requirements and
Guidelines [Including: Technical Corrigendum (2005)]
60601-1-2 (2007): Medial Electrical Equipment – Part 1-2: General
requirements for basic safety and essential Performance – Collateral
Standard: Electromagnetic Compatibility – Requirements and Tests
The Risk analysis was completed and risk control implemented to mitigate
identified hazards. The testing results supports that all the software
specifications have met the acceptance criteria. Testing for verification and
validation of the device was found acceptable to support the claims of
substantial equivalence.
Software Verification and Validation
Software Documentation for a Moderate Level of Concern software per
FDA’s Guidance Document “Guidance for the Content of Premarket
Submissions for Software Contained in Medical Devices” issued on May 11,
2005 is also included as part of this submission.
Summary
Performance tests were conducted to test the functionality of the SOMATOM
Scope/Scope Power configured with software version SOMARIS/5 VC30
syngo® CT VC30-easyIQ version. These tests have been performed to test
the ability of the included features of the subject device. The results of these
tests demonstrate that the subject device performs as intended. The result of
all conducted testing was found acceptable to support the claim of substantial
equivalence.